Quantitative cardiovascular magnetic resonance for molecular imaging

[1]  Ciprian Catana,et al.  Bimodal MR-PET agent for quantitative pH imaging. , 2010, Angewandte Chemie.

[2]  Dudley J. Pennell,et al.  Cardiovascular Magnetic Resonance , 2010, Circulation.

[3]  G. V. van Dam,et al.  Advanced carotid plaque imaging. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  A. Beek,et al.  Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction , 2010, Heart.

[5]  Albert J. Sinusas,et al.  PET and SPECT in cardiovascular molecular imaging , 2010, Nature Reviews Cardiology.

[6]  Elmar Spuentrup,et al.  Thrombus Imaging With Fibrin-Specific Gadolinium-Based MR Contrast Agent EP-2104R: Results of a Phase II Clinical Study of Feasibility , 2009, Investigative radiology.

[7]  R. Kwong,et al.  Clinical application of cardiac CMR. , 2009, Reviews in cardiovascular medicine.

[8]  R. Razavi,et al.  Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[9]  René M. Botnar,et al.  Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. , 2009, JACC. Cardiovascular imaging.

[10]  Fahmeed Hyder,et al.  Neurophysiology of functional imaging , 2009, NeuroImage.

[11]  Katherine C. Wu,et al.  Reduced Myocardial Creatine Kinase Flux in Human Myocardial Infarction: An In Vivo Phosphorus Magnetic Resonance Spectroscopy Study , 2009, Circulation.

[12]  J. Tacke,et al.  Molecular Magnetic Resonance Imaging of Deep Vein Thrombosis Using a Fibrin-Targeted Contrast Agent: A Feasibility Study , 2009, Investigative radiology.

[13]  K. Takeda,et al.  Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: Estimation from CT data , 2009, Journal of magnetic resonance imaging : JMRI.

[14]  D. Sept,et al.  Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging , 2008, Magnetic resonance in medicine.

[15]  Samuel A Wickline,et al.  Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy , 2008, Magnetic resonance in medicine.

[16]  Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies. , 2008, Radiology.

[17]  Samuel A Wickline,et al.  Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[18]  Shelton D Caruthers,et al.  Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. , 2008, JACC. Cardiovascular imaging.

[19]  D. Kraitchman,et al.  Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. , 2008, Journal of the American College of Cardiology.

[20]  D. Kraitchman,et al.  Positive contrast MR‐lymphography using inversion recovery with ON‐resonant water suppression (IRON) , 2008, Journal of magnetic resonance imaging : JMRI.

[21]  Peter Caravan,et al.  EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. , 2008, Journal of the American Chemical Society.

[22]  S. Achilefu,et al.  Multimodality Molecular Imaging with Combined Optical and SPECT/PET Modalities , 2008, Journal of Nuclear Medicine.

[23]  D. Sosnovik.  Molecular Imaging in Cardiovascular Magnetic Resonance Imaging: Current Perspective and Future Potential , 2008, Topics in magnetic resonance imaging : TMRI.

[24]  R. Mason,et al.  Physical principles of quantitative nuclear magnetic resonance oximetry. , 2008, Frontiers in bioscience : a journal and virtual library.

[25]  Matthias Stuber,et al.  Positive contrast visualization of iron oxide‐labeled stem cells using inversion‐recovery with ON‐resonant water suppression (IRON) , 2007, Magnetic resonance in medicine.

[26]  René M. Botnar,et al.  Molecular MR Imaging of Human Thrombi in a Swine Model of Pulmonary Embolism Using a Fibrin-Specific Contrast Agent , 2007, Investigative radiology.

[27]  Garry E. Kiefer,et al.  Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles , 2007 .

[28]  S. Caruthers,et al.  Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles. , 2007, International journal of cancer.

[29]  D. Pennell,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Feasibility and Initial Experience of Assessment of Mechanical Dyssynchrony Using Cardiovascular Magnetic Resonance and Semi-automatic Border Detection , 2008 .

[30]  Renu Virmani,et al.  Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.

[31]  Ralph Weissleder,et al.  Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.

[32]  Xiaoping Hu,et al.  Off‐resonance saturation as a means of generating contrast with superparamagnetic nanoparticles , 2006, Magnetic resonance in medicine.

[33]  Robert G. Weiss,et al.  Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium , 2006, Circulation.

[34]  Debiao Li,et al.  Generating positive contrast from off-resonant spins with steady-state free precession magnetic resonance imaging: theory and proof-of-principle experiments , 2006, Physics in medicine and biology.

[35]  V. Fuster,et al.  MRI to detect atherosclerosis with gadolinium‐containing immunomicelles targeting the macrophage scavenger receptor , 2006, Magnetic resonance in medicine.

[36]  Samuel A. Wickline,et al.  Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis , 2006 .

[37]  Shelton D Caruthers,et al.  In Vitro Demonstration Using 19F Magnetic Resonance to Augment Molecular Imaging With Paramagnetic Perfluorocarbon Nanoparticles at 1.5 Tesla , 2006, Investigative radiology.

[38]  Kathryn Sharer,et al.  In vivo detection of single cells by MRI , 2006, Magnetic resonance in medicine.

[39]  Zahi A Fayad,et al.  Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): Sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T , 2006, Magnetic resonance in medicine.

[40]  Shelton D Caruthers,et al.  Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[41]  S. Gambhir,et al.  Quantitative PET Imaging of Tumor Integrin αvβ3 Expression with 18F-FRGD2 , 2006 .

[42]  M. Dewhirst,et al.  Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. , 2006, Magnetic resonance in medicine.

[43]  S. Gambhir,et al.  Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  Sukho Lee,et al.  Evaluating Mid-(k, n) Queries Using B+-Tree , 2005, DEXA.

[45]  René M. Botnar,et al.  Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. , 2005, American journal of respiratory and critical care medicine.

[46]  René M. Botnar,et al.  Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model , 2005, Circulation.

[47]  J. Ronald,et al.  Development of aortic valve sclerosis in a rabbit model of atherosclerosis: an immunohistochemical and histological study. , 2005, The Journal of heart valve disease.

[48]  John M Pauly,et al.  Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles , 2005, Magnetic resonance in medicine.

[49]  Paul A Bottomley,et al.  ATP flux through creatine kinase in the normal, stressed, and failing human heart. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Chun Li,et al.  Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to alpha v beta 3 receptor expressed in Kaposi's sarcoma. , 2005, Molecular imaging.

[51]  Mathias Langer,et al.  High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. , 2005, AJR. American journal of roentgenology.

[52]  Patrick J. Gaffney,et al.  Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .

[53]  Zahi A Fayad,et al.  Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.

[54]  René M. Botnar,et al.  In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.

[55]  Heather Kalish,et al.  Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. , 2004, Blood.

[56]  Bobbi K Lewis,et al.  In vivo trafficking and targeted delivery of magnetically labeled stem cells. , 2004, Human gene therapy.

[57]  Martin J Graves,et al.  In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI , 2004, Stroke.

[58]  V. Fuster,et al.  Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging , 2004, Circulation.

[59]  René M. Botnar,et al.  In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent , 2004, Circulation.

[60]  Ralph Weissleder,et al.  Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.

[61]  Shelton D Caruthers,et al.  Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.

[62]  Scott E. Fraser,et al.  Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study , 2004, NeuroImage.

[63]  Ralph Weissleder,et al.  Peroxidase Substrate Nanosensors for MR Imaging , 2004 .

[64]  Samuel A Wickline,et al.  Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles. , 2004, Magnetic resonance in medicine.

[65]  Dawen Zhao,et al.  Measuring changes in tumor oxygenation. , 2004, Methods in enzymology.

[66]  R. Weissleder,et al.  Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. , 2003, Bioconjugate chemistry.

[67]  Sheng-Kwei Song,et al.  Improved molecular imaging contrast agent for detection of human thrombus , 2003, Magnetic resonance in medicine.

[68]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[69]  J. Couet,et al.  Experimental aortic valve stenosis in rabbits. , 2003, Journal of the American College of Cardiology.

[70]  Robert J Gillies,et al.  Renal and systemic pH imaging by contrast‐enhanced MRI , 2003, Magnetic resonance in medicine.

[71]  Bernard Gallez,et al.  How does blood oxygen level‐dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? , 2002, Magnetic resonance in medicine.

[72]  D. Heudes,et al.  Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[73]  Kerry K. Karukstis,et al.  Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.

[74]  Ralph Weissleder,et al.  Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.

[75]  S. Schmitz,et al.  Iron-Oxide-Enhanced Magnetic Resonance Imaging of Atherosclerotic Plaques: Postmortem Analysis of Accuracy, Inter-Observer Agreement, and Pitfalls , 2002, Investigative Radiology.

[76]  R. Bonow,et al.  Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve , 2002, Circulation.

[77]  H. Kato.  Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[78]  Ralph Weissleder,et al.  Annexin V–CLIO: A Nanoparticle for Detecting Apoptosis by MRI , 2002, Molecular imaging.

[79]  Alexander Petrovsky,et al.  Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. , 2002, Bioconjugate chemistry.

[80]  R Weissleder,et al.  Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.

[81]  B Hamm,et al.  Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles , 2001, Journal of magnetic resonance imaging : JMRI.

[82]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[83]  R. Gillies,et al.  Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. , 2001, Neoplasia.

[84]  B. Han,et al.  Takayasu's arteritis: assessment of disease activity with contrast-enhanced MR imaging. , 2000, AJR. American journal of roentgenology.

[85]  S. Schmitz,et al.  Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. , 2000, Investigative radiology.

[86]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[87]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[88]  W. R. Lee,et al.  Takayasu's arteritis: assessment of disease activity with contrast-enhanced MR imaging. , 2000, AJR. American journal of roentgenology.

[89]  H. Harashima,et al.  Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes. , 1999, Advanced drug delivery reviews.

[90]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[91]  S. Oh,et al.  Experimental hypercholesterolemia induces ultrastructural changes in the elastic laminae of rabbit aortic valve. , 1998, Yonsei medical journal.

[92]  W Semmler,et al.  Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways , 1998, Magnetic resonance in medicine.

[93]  R. Erickson,et al.  Promoter activity of carbonic anhydrase II regulatory regions in cultured renal proximal tubular cells. , 1998, Life sciences.

[94]  M. Mathy-Hartert,et al.  Perfluorocarbons as oxygen carriers , 1998 .

[95]  R. Bruno,et al.  Pharmacokinetic and pharmacodynamic properties of docetaxel: results of phase I and phase II trials. , 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[96]  M. Paillard.  Na+/H+ exchanger subtypes in the renal tubule: function and regulation in physiology and disease. , 1997, Experimental nephrology.

[97]  P. Antich,et al.  Hexafluorobenzene: a Sensitive 19F NMR Indicator of Tumor Oxygenation , 1996, NMR in biomedicine.

[98]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[99]  T. Inubushi,et al.  Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. , 1995, Circulation.

[100]  B. Dardzinski,et al.  Rapid tissue oxygen tension mapping using 19F inversion‐recovery echo‐planar imaging of P erfluoro‐15 ‐crown‐5‐ether , 1994, Magnetic resonance in medicine.

[101]  D. Hanahan,et al.  Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice , 1994, Journal of virology.

[102]  P. Antich,et al.  In vivo oxygen tension and temperature: Simultaneous determination using 19F NMR spectroscopy of perfluorocarbon , 1993, Magnetic resonance in medicine.

[103]  P. Antich,et al.  Effect of homonuclear J modulation on 19F spin‐echo images , 1991, Magnetic resonance in medicine.

[104]  P. Antich,et al.  Perfluorocarbon imaging in vivo: a 19F MRI study in tumor-bearing mice. , 1989, Magnetic resonance imaging.

[105]  J. Cuppen,et al.  RLSQ: T1, T2, and ρ calculations, combining ratios and least squares , 1987 .

[106]  J. Cuppen,et al.  RLSQ: T1, T2, and rho calculations, combining ratios and least squares. , 1987, Magnetic resonance in medicine.

[107]  M. Stébé,et al.  Solute-solvent interactions in perfluorocarbon solutions of oxygen. An NMR study , 1981 .

[108]  M. Stébé,et al.  Fluorocarbons as oxygen carriers. II. An NMR study of partially or totally fluorinated alkanes and alkenes , 1981 .